乳腺癌中PD-L1和PD-L2蛋白的不同细胞表达模式
Julie M Jorns1, Yunguang Sun1, Sailaja Kamaraju2
1Department of Pathology, Froedtert and Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Journal of personalized medicine
|May 25, 2024
概括
编程死亡配体1 (PD-L1) 和PD-L2的表达在乳腺癌 (BC) 细胞和免疫细胞中不同. PD-L2可以补充PD-L1测试,用于选择患者接受抗PD-1免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物标志物研究 生物标志物研究
背景情况:
- 编程死亡配体1 (PD-L1) 免疫组织化学 (IHC) 是预测乳腺癌 (BC) 对抗PD-1免疫疗法的反应的标准.
- 相关的配体PD-L2研究较少,但可以提供补充的预测价值.
研究的目的:
- 研究乳腺癌中PD-L1和PD-L2的独特表达模式.
- 评估PD-L2作为PD-L1的潜在补充生物标志物,用于预测ER+乳腺癌中抗PD-1治疗反应.
主要方法:
- 在32个乳腺癌样本中使用免疫组织化学对PD-L1和PD-L2表达的前性分析.
- 在癌细胞与免疫细胞中对PD-L1和PD-L2阳性的比较.
- 对PD-L1和PD-L2表达水平的相关性分析.
- 在雌激素受体阳性 (ER+) 瘤中评估PD-L1和PD-L2阳性.
主要成果:
- 免疫细胞中的PD-L1阳性显著高于癌细胞 (中位数为5.0%),而不是癌细胞 (中位数为0.0%).
- 癌细胞中PD-L2阳性显著高于免疫细胞 (中位数为30%) (中位数为5.0%).
- 在癌症或免疫细胞中,PD-L1和PD-L2表达水平没有相关性.
- 在ER+瘤 (n=23) 中,73.9%为PD-L2阳性,而40.9%为PD-L1阳性 (切割点≥1%).
结论:
- 乳腺癌中PD-L1和PD-L2的不同表达表明了不同的调节机制.
- PD-L2 IHC可以作为PD-L1的宝贵补充生物标志物.
- 结合PD-L1和PD-L2评估可以改善患者选择抗PD-1疗法,特别是在侵袭性ER+乳腺癌中.
更多相关视频
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.6K
10:11Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
23.1K
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
